Real-world experience with sipuleucel-T (Sip-T) in Asian men with castrate-resistant prostate cancer (CRPC).

Jingsong Zhang,Ming Liu,Jiahua Pan,Xiao X. Wei,Matthew Harmon,John Azzolina,Scott C. Flanders

Real-world experience with sipuleucel-T (Sip-T) in Asian men with castrate-resistant prostate cancer (CRPC).

2020

Jingsong Zhang
Ming Liu
Jiahua Pan
Xiao X. Wei
Matthew Harmon
John Azzolina
Scott C. Flanders

e17588Background: Clinical trials of sip-T predominately included white men (over 90%). Previously we explored outcomes with sip-T in white and black patients (pts) (Kantoff PW, NEJM 2010; Sartor A...

Keywords:

Castrate-resistant prostate cancer
Oncology
Internal medicine
Sipuleucel-T
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations